Financial Performance - Blade Air Mobility, Inc. reported a quarterly loss of $0.13 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.12, but an improvement from a loss of $0.23 per share a year ago, indicating an earnings surprise of -8.33% [1] - The company posted revenues of $54.36 million for the quarter ended December 2024, surpassing the Zacks Consensus Estimate by 6.91%, compared to year-ago revenues of $47.48 million [2] - Over the last four quarters, Blade Air Mobility has surpassed consensus EPS estimates two times and topped consensus revenue estimates four times [2] Stock Performance - Blade Air Mobility shares have declined approximately 33.4% since the beginning of the year, contrasting with the S&P 500's decline of -4.8% [3] - The current consensus EPS estimate for the upcoming quarter is -$0.13 on revenues of $52.87 million, and for the current fiscal year, it is -$0.27 on revenues of $257.88 million [7] Industry Outlook - The Technology Services industry, to which Blade Air Mobility belongs, is currently ranked in the top 30% of over 250 Zacks industries, suggesting a favorable outlook compared to the bottom 50% [8] - The performance of Blade Air Mobility's stock may be influenced by the overall industry outlook, as empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions [5][8]

Business Operations - Blade acquired ten fixed wing aircraft dedicated to the Medical segment, expected to account for approximately 17% of total flight costs and nearly one-third of Medical segment flying [26][28]. - Approximately 47% of Blade's flight costs in 2024 were pursuant to capacity purchase agreements (CPAs) that included flight volume guarantees [28]. - The asset-light business model allows Blade to utilize third-party aircraft, creating a predictable and flexible cost structure while minimizing economic risk [24][25]. - Blade's competitive strategy focuses on technology-enabled services and a diverse fleet to lower costs and improve customer satisfaction in both passenger and medical segments [36][39]. - The company discontinued certain flight services, including by-the-seat jet flights between New York and South Florida, to streamline operations [26]. Technology and Innovation - Blade's proprietary technology stack enables real-time tracking of organ transports and passenger flights, enhancing operational efficiency and scalability [29]. - The company aims to leverage Electric Vertical Aircraft (EVA) technology to reduce operating costs and transition to quieter, emission-free air mobility [30]. - Blade's MediMobility Organ Transport service includes logistics coordination and support for evaluating potential donor organs, enhancing efficiency in organ transportation [23][27]. Workforce and Employment - The company has a total of 322 employees, with 199 in the Medical segment and 91 in the Passenger segment, indicating a strong operational workforce [40]. Regulatory Compliance - Blade's operations are subject to various regulatory environments, including compliance with the U.S. Department of Transportation and Federal Aviation Administration regulations [41]. - The company is subject to various federal, state, and local environmental laws, including regulations on the discharge of materials and aircraft noise [57]. - The company must comply with HIPAA regulations regarding the handling of Protected Health Information (PHI), which includes implementing safeguards to ensure confidentiality and integrity [51]. - The company may face penalties under HIPAA for failing to comply with privacy and security regulations, including potential fines and lawsuits [51]. - The company is required to notify affected individuals and authorities in the event of a breach of unsecured PHI, particularly if it affects 500 or more individuals [51]. - The company is subject to fraud and abuse laws, including the federal Anti-Kickback Statute, which prohibits certain financial relationships that could influence referrals for healthcare services [53]. - Violations of fraud and abuse laws could result in significant civil and criminal penalties, including exclusion from federal healthcare programs [56]. - The company must provide specific notices to users regarding data collection and processing under regulations like GDPR and CCPA [49]. - The company is required to appoint a data protection officer to ensure compliance with GDPR regulations [48]. Company History - The company was previously known as Experience Investment Corp. and changed its name to Blade Air Mobility, Inc. after acquiring Blade Urban Air Mobility, Inc. in 2021 [58]. Financial Information - The company’s financial reports and other important information are available on its Investor Relations website and are filed with the SEC [59].

Blade Air Mobility, Inc. (NASDAQ:BLDE) Q4 2024 Earnings Conference Call March 13, 2025 8:00 AM ET Company Participants Matthew Schneider - Vice President, Investor Relations and Strategic Finance Robert Wiesenthal - Chief Executive Officer William Heyburn - Chief Financial Officer Conference Call Participants Jason Helfstein - Oppenheimer Edison Yu - Deutsche Bank Bill Peterson - JPMorgan Ben Klieve - Lake Street Capital Markets Operator Good morning, ladies and gentlemen, and welcome to the Blade Air Mobil ...

Financial Performance - Q4 2024 revenue increased by 14.5% to $54.4 million compared to $47.5 million in Q4 2023, with a 22.1% increase excluding Canada[11] - Full-year net loss improved by $28.8 million to $(27.3) million in FY 2024, while Adjusted EBITDA improved by $17.8 million to $1.2 million[5] - Total revenue for the year ended December 31, 2024, reached $248,693,000, up from $225,180,000 in 2023, reflecting an increase of 10.4%[26] - Revenue for Q4 2024 was $54,357,000, an increase of 14.5% compared to $47,478,000 in Q4 2023[26] - Adjusted EBITDA for the year ended December 31, 2024, was $1,205,000, compared to a loss of $16,633,000 in 2023, showing a positive turnaround[53] - Adjusted EBITDA for Q4 2024 was $(387) million, an improvement from $(5,248) million in Q4 2023[44] Segment Performance - Medical Segment Adjusted EBITDA increased by 119.6% to $5.5 million in Q4 2024, driven by 13.7% revenue growth[5] - Passenger Segment Adjusted EBITDA for FY 2024 was $3.6 million, an increase of $8.6 million year-over-year[5] - MediMobility Organ Transport revenue for Q4 2024 was $36,388,000, contributing significantly to the total revenue[57] - Medical segment revenue grew to $36,388 million in Q4 2024, compared to $31,991 million in Q4 2023, marking an increase of 13.0%[37] Cash Flow and Assets - Operating Cash Flow improved by $7.6 million to $(1.8) million in Q4 2024, with Free Cash Flow Before Aircraft Acquisitions increasing by $5.8 million to $(3.6) million[11] - The company ended FY 2024 with $127.1 million in cash and short-term investments[11] - Free Cash Flow for the year ended December 31, 2024, was $(27,307,000), compared to $(56,076,000) in 2023, indicating an improvement[30] - Cash and cash equivalents at the end of Q4 2024 were $18,378,000, down from $27,873,000 at the end of Q4 2023, a decrease of 34%[24] - Total current assets decreased to $160,742,000 as of December 31, 2024, down from $206,261,000 in 2023, a decline of 22%[24] Loss and Expenses - Net loss for Q4 2024 was $(9,793,000), an improvement from $(33,941,000) in Q4 2023[26] - Operating expenses for Q4 2024 totaled $62,729,000, a decrease of 24.5% compared to $83,111,000 in Q4 2023[26] - Total operating expenses for Q4 2024 were $62,729 million, down from $83,111 million in Q4 2023[50] - Adjusted SG&A for Q4 2024 was $13,618 million, a slight decrease from $14,338 million in Q4 2023, with SG&A as a percentage of revenue improving to 25.1%[50] Future Outlook - The company expects revenue for FY 2025 to be between $245 million and $265 million, with double-digit millions of Adjusted EBITDA[15] - The company is focused on expanding its fleet and entering new markets, with plans for future product lines and partnerships[60] - New mobile app launched in March 2025 to enhance user experience and flight booking[15] Operational Changes - The company discontinued operations in Canada on August 31, 2024, which may impact future revenue comparisons[22] - Total liabilities decreased to $34,737,000 as of December 31, 2024, down from $60,638,000 in 2023, a reduction of 42.7%[24] Flight Performance - Flight Profit rose by 39.7% to $12.6 million in Q4 2024, with Flight Margin improving to 23.2% from 19.0% in the prior year[11] - Total flight profit for Q4 2024 was $12,589 million, a significant rise from $9,010 million in Q4 2023, reflecting a 39.5% increase[44] - The flight margin improved to 23.2% in Q4 2024, compared to 19.0% in Q4 2023[44] Revenue Breakdown - Passenger revenue increased to $17,969 million in Q4 2024, up from $15,487 million in Q4 2023, representing a growth of 16.0%[37] - Short Distance revenue decreased by 14.7% to $9.1 million in Q4 2024, but increased by 17.7% excluding Canada[11] - Revenue excluding Canada for Q4 2024 was $54,357 million, a 22.1% increase from $44,536 million in Q4 2023[35] - Short distance revenue decreased to $9,133 million in Q4 2024, down 14.7% from $10,703 million in Q4 2023[35]

Full-year net loss improved by $28.8 million versus the prior year to $(27.3) million in FY 2024; Adjusted EBITDA improved by $17.8 million versus the prior year to $1.2 million in FY 2024(1)Full-year Passenger Segment Adjusted EBITDA of $3.6 million in 2024 represents an $8.6 million increase versus the prior year Q4 revenue increased 14.5% versus the prior year to $54.4 million in 2024. Excluding Canada, which we exited in August 2024, revenue increased 22.1% versus the prior year period(1)Net loss improv ...

Pilot program to inform Skyports and Blade about commuter demand, ground operation best practices and consumer experience ahead of eVTOL deploymentNEW YORK, March 10, 2025 (GLOBE NEWSWIRE) -- Blade Air Mobility, Inc. (Nasdaq: BLDE, “Blade”), a technology-powered global air mobility platform, and Skyports Infrastructure (“Skyports”), a leading provider of ground infrastructure for advanced air mobility, announced an alliance today to launch a pilot program that will expand Blade’s existing by-the-seat helico ...

Core Points - Blade Air Mobility, Inc. announced the opening of a shareholder Q&A platform for its upcoming conference call to discuss financial results for Q4 and fiscal year ended December 31, 2024 [1][2] - The conference call is scheduled for March 13, 2025, at 8:00 am ET [1] - Shareholders can submit and upvote questions until March 12, 2025, at 9:30 am ET [2] Company Overview - Blade Air Mobility provides air transportation and logistics services, primarily for hospitals in the U.S., and is a major transporter of human organs for transplant [4] - The company operates helicopter and fixed-wing services mainly in the Northeast U.S. and Southern Europe [4] - Blade's asset-light model and exclusive passenger terminal infrastructure aim to facilitate a seamless transition to Electric Vertical Aircraft (EVA or eVTOL), promoting lower-cost, quiet, and emission-free air mobility [4]

Company Overview - Blade Air Mobility, Inc. is a provider of air transportation and logistics services, primarily for hospitals in the U.S., and is one of the largest transporters of human organs for transplant [4] - The company offers helicopter and fixed-wing services mainly in the Northeast U.S. and Southern Europe, utilizing an asset-light model and exclusive passenger terminal infrastructure [4] - Blade is focused on transitioning to Electric Vertical Aircraft (EVA or eVTOL) to enable lower-cost, quiet, and emission-free air mobility [4] Upcoming Conference Call - Blade will hold a conference call to discuss its financial results for Q4 and the fiscal year ended December 31, 2024, on March 13, 2025, at 8:00 AM ET [1] - A shareholder Q&A platform has been opened for shareholders to submit and upvote questions for management prior to the call, available until March 12, 2025, at 9:30 AM ET [2] - The audio-only webcast of the call can be accessed from the company's website, with a replay available for one year [3]

Core Viewpoint - Blade Air Mobility, Inc. (BLDE) is expected to report a year-over-year increase in earnings driven by higher revenues, with the actual results being crucial for stock price movement [1][2]. Earnings Expectations - The earnings report is anticipated on March 13, 2025, with a consensus estimate of a quarterly loss of $0.12 per share, reflecting a year-over-year change of +47.8% [3]. - Revenues are projected to be $50.84 million, which is a 7.1% increase from the same quarter last year [3]. Estimate Revisions - The consensus EPS estimate has been revised down by 13.64% over the last 30 days, indicating a bearish sentiment among analysts regarding the company's earnings prospects [4][10]. - The Most Accurate Estimate is lower than the Zacks Consensus Estimate, resulting in an Earnings ESP of -28.51%, complicating predictions for an earnings beat [10][11]. Earnings Surprise Prediction - The Zacks Earnings ESP model suggests that a positive or negative reading indicates the likely deviation of actual earnings from the consensus estimate, with positive readings being more predictive of earnings beats [6][7]. - Blade Air Mobility's current Zacks Rank is 3 (Hold), which, combined with the negative Earnings ESP, makes it challenging to predict an earnings beat [11]. Historical Performance - In the last reported quarter, Blade Air Mobility was expected to post a loss of $0.06 per share but actually reported a loss of $0.03, resulting in a surprise of +50% [12]. - Over the past four quarters, the company has surpassed consensus EPS estimates twice [13]. Conclusion - While Blade Air Mobility does not appear to be a strong candidate for an earnings beat, investors should consider other factors before making investment decisions [16].

Company Overview - Blade Air Mobility, Inc. is a technology-powered air mobility platform that provides air transportation and logistics services, particularly for hospitals in the U.S. and for passengers in the Northeast U.S. and Southern Europe [2] - The company is one of the largest transporters of human organs for transplant and operates an asset-light model with exclusive passenger terminal infrastructure and proprietary technologies [2] Upcoming Events - Rob Wiesenthal, the CEO of Blade, will present at the 2025 J.P. Morgan Industrials Conference on March 13, 2025, at 9:45 am ET, with a webcast available for investors [1] Business Model and Technology - Blade's business model is designed to facilitate a seamless transition from traditional air transport methods to Electric Vertical Aircraft (EVA or eVTOL), aiming for lower-cost, quiet, and emission-free air mobility [2]